Prosecution Insights
Last updated: October 27, 2026

Connor Kennedy English, USPTO Patent Examiner

Listed by the USPTO as ENGLISH, CONNOR KENNEDY

Tech Center 1600 • Art Units: 1625 1629 1631 1692

This examiner grants 59% of resolved cases

Analysis

ENGLISH, CONNOR KENNEDY examines in tech center 1600 and art unit 1625. The record includes 54 resolved cases, with an allowance rate of 59.3%. The median time to allowance is 1244 days. The limited record warrants caution, but the observed allowance rate is above half and the timeline indicates that prosecution may remain extended.

The interview lift is 50.3%, showing a strong positive association between interviews and allowance outcomes. Chiesi Farmaceutici S.p.a., Novartis AG, and Merck Patent GmbH are the listed top companies. The listed firms are Knobbe, Martens, Olson & Bear, LLP, WILSON SONSINI GOODRICH & ROSATI, and ARENTFOX SCHIFF LLP. Practitioners may give interviews meaningful consideration when they can address defined claim issues.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

59.3%
Allow Rate
-0.7% vs TC avg
93
Total Applications
+50.3%
Interview Lift
1244
Avg Prosecution Days
Based on 54 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
10.9%
§102 Novelty
35.7%
§103 Obviousness
35.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18559859 DOSING REGIMENS Non-Final OA Novartis AG
18705770 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS Non-Final OA Merck Patent GmbH
17800516 Inhibitors of Human Herpesviruses Non-Final OA The Governors of the University of Alberta
17821931 COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 MUTATIONS Non-Final OA Board of Regents, The University of Texas System
18835778 SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF Non-Final OA Arizona Board of Regents on Behalf of the University of Arizona
18717962 CANNABICHROMENEQUINONE AND ANALOGUES THEREOF, AND METHOD OF USING COMPOSITIONS THEREOF AS ANTI-INFLAMMATORY AGENTS Final Rejection Juva Life, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Connor Kennedy English's allowance rate?

59.3% of resolved applications examined by Connor Kennedy English were allowed (54 resolved cases), compared with 51.6% across Art Unit 1625 over the last five years.

Does an interview help with examiner Connor Kennedy English?

This examiner's interview lift is +50.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Connor Kennedy English take to allow a patent?

Applications allowed by Connor Kennedy English took 1,244 days on average from filing to allowance.

Which art unit does examiner Connor Kennedy English work in?

Connor Kennedy English examines applications in Art Unit 1625 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month